Skip to main content

Month: January 2025

Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial

Written by Customer Service on . Posted in Public Companies.

SARASOTA, FL, Jan. 08, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for patent application 17/954,864 for “Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.” Following receipt of the Notice of Allowance, Silo filed the final issue paperwork, paid the issue fees, and expects formal issuance of the patent in the next 90 days The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent...

Continue reading

Matador Technologies Inc. Announces Market Making Partnership with Independent Trading Group

Written by Customer Service on . Posted in Public Companies.

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) — Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA) announces that it has entered into a Market Making Services Agreement with Independent Trading Group, Inc. (“ITG”), effective January 6, 2025. This partnership is designed to enhance the liquidity and efficiency of trading in Matador’s securities on Canadian exchanges. Independent Trading Group specializes in providing high-quality, consistent market-making services. Based in Toronto, ITG brings decades of expertise and a reputation for excellence in maintaining market stability and depth across various industries. Key Agreement Details:Scope of Services: ITG will leverage its expertise to improve liquidity, reduce volatility, and enhance the trading experience for Matador’s securities. Compensation: ITG will receive...

Continue reading

SELLAS Announces Key Business Objectives for 2025

Written by Customer Service on . Posted in Public Companies.

– Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 – – SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expected in 1H 2025 – – Approval of “tambiciclib” as Recommended International Nonproprietary Name for SLS009 – – Applied for Non-Dilutive Grant Funding to Expand SLS009 Development Into Frontline Setting in AML – – Developing SLS009 Pediatric Programs in Hematological and Potentially Other Malignancies – – Company to Host Corporate Update Webinar Today, January 8, 2025, at 9:00 am ET – NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the...

Continue reading

Lever Expands Team and Technology to Address Challenges in Regulated Consumer Debt Markets

Written by Customer Service on . Posted in Public Companies.

Lever Scales Operations to Tackle Consumer Debt Challenges for Millennial Borrowers LOS ANGELES, Jan. 08, 2025 (GLOBE NEWSWIRE) — AI Unlimited (AIUG:OTCQB) subsidiary Lever, a trailblazer in liability management, is building on its momentum in 2025 with an expanded focus on addressing the challenges of regulated consumer debt markets. As the platform scales to include new consumer debt verticals, its team is growing across development and AI R&D to enhance its capabilities for tackling the unique financial pressures faced by millennial users. The Growing Consumer Debt Landscape Millennials, a generation disproportionately impacted by student loan debt and rising living costs, represent a core demographic for Lever’s platform. With over 45% of millennials carrying student loan debt and average consumer liabilities exceeding...

Continue reading

Edible Garden Achieves Over 45% Year-Over-Year Increase in Preliminary Herbs and Produce Sales Results During Key Holiday Time Period

Written by Customer Service on . Posted in Public Companies.

Commitment to Zero-Waste Inspired® Mission and Consistently Strong Fill Rates Fuel Growth BELVIDERE, NJ, Jan. 08, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that the Company experienced a more than 45% year-over-year increase in preliminary herbs and produce sales results for the key holiday time period.1 “We are incredibly proud of Edible Garden’s exceptional performance this holiday season, which was marked by an impressive year-over-year growth in herbs and produce sales exceeding 45%,” said Jim Kras, Chief Executive Officer of Edible Garden. “Building on the momentum of a record-breaking Thanksgiving period2,...

Continue reading

Bridger Aerospace Congratulates Our Founder Timothy Sheehy for Being Sworn in as United States Senator for the State of Montana

Written by Customer Service on . Posted in Public Companies.

BELGRADE, Mont., Jan. 08, 2025 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today congratulates Timothy P. Sheehy, the Company’s founder and former chief executive officer of the Company, for being sworn into the United States Senate as the U.S. Senator for the State of Montana. “We are extremely proud of the leadership and sacrifices that Tim has made for the country, and we are confident Tim will continue his legacy of success in the U.S. Senate,” stated Jeff Kelter, the Company’s Executive Chairman of the Board of Directors. Tim has a history of distinguished service to the country, including years of service as a Naval SEAL Officer and team leader, as well as being the recipient of the Bronze Star...

Continue reading

SiTime Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

Written by Customer Service on . Posted in Public Companies.

SANTA CLARA, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) — SiTime Corporation (Nasdaq: SITM), the Precision Timing company, will announce its fourth quarter 2024 financial results on Wednesday, February 5, 2025, after market close. Rajesh Vashist, chief executive officer, and Beth Howe, chief financial officer, will broadcast a conference call at 2:00 p.m. Pacific Time to discuss the company’s results. Analysts and investors are invited to join the conference call using the following information: Date: Wednesday, February 5, 2025Time: 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)Live webcast: Click Here Register for dial-in number: Click Here Advanced registration is required for dial-in participants. Please complete the linked registration form above to receive a dial-in number and dedicated PIN for accessing the conference call....

Continue reading

APA Corporation Announces Expiration and Final Results of Private Exchange Offers, Tender Offers, and Consent Solicitations and Waiver of Financing Condition

Written by Customer Service on . Posted in Public Companies.

HOUSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) — APA Corporation (“APA”) (Nasdaq: APA) announced today the final results as of 5:00 p.m., New York City time, on January 7, 2025 (the “Expiration Time”) of the previously announced (i) offers to exchange (the “Exchange Offers”) any and all validly tendered and accepted notes and debentures listed in the table below issued by Apache Corporation, its wholly-owned subsidiary (“Apache”), for new notes to be issued by APA (the “APA Notes”), (ii) offers to purchase for cash (the “Tender Offers” and together with the Exchange Offers, the “Offers”) up to $1,000,000,000 aggregate principal amount of any and all validly tendered and accepted Apache Notes of certain series (the “Apache Tender Notes”), and (iii) solicitations of consents (the “Consent Solicitations”) to certain proposed amendments (the...

Continue reading

Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline

Written by Customer Service on . Posted in Mergers And Acquisitions.

All-Stock Acquisition Strategy Targets Multiple Small Companies with FDA-Approved Products to Drive Growth and Shareholder Value WARRINGTON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced it has launched a new corporate strategy to become a revenue generating biotech company through acquisitions of small companies and their FDA-approved products while the Company continues to progress its cardiovascular and oncology development pipeline. The Company will seek acquisition targets to achieve the Company’s new corporate strategy. Windtree believes there is an opportunity in the market: the acquisition of small companies with FDA-approved...

Continue reading

SMC Entertainment Closes Acquisition of Boutique Investment Manager, Bateau Asset Management, Providing Entry to Australian and Southeast Asian Financial Services Markets

Written by Customer Service on . Posted in Mergers And Acquisitions.

Bateau Asset Management brings to SMC Entertainment:Foundational acquisition into International Financial Services Sector Well-established client base of high-net-worth individuals Experienced global client services team based in Australia and Singapore Research and advisory capabilities complementary to SMC Entertainment’s Fintech platformBOCA RATON, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) — SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC PINK: SMCE), a Fintech incubator company focused on acquisition and support of commercialized financial services and technology (Fintech) companies, is pleased to announce that it has closed the Acquisition Agreement to acquire a 100% interest in Australia-based Bateau Asset Management, a boutique investment manager (“Bateau”). The acquisition will provide SMC with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.